The European Union (EU) medicines regulator, the European Medicines Agency (EMA), has reported that the BioNTech-Pfizer vaccine developed against the new type of coronavirus (Kovid-19) can be stored under normal conditions refrigerator up to 1 month.
While the vaccine in question was previously stored at minus 80 degrees Celsius for up to 5 days, it can now be stored at normal refrigerator temperatures (between 2 and 8 degrees Celsius) for 1 month (31 days). decision taken by the EMA.
The EMA has announced changes to the recommendation on the storage conditions of the vaccine called “Comirnaty” developed by BioNTech and Pfizer.
In the statement, which pointed out that additional studies had been carried out on vaccine storage conditions, it was stated that unopened vaccine vials taken out of the freezer could be stored for up to 31 days instead of 5 days under cold conditions. normal refrigerator. at 2 to 8 degrees.
In the statement, it was pointed out that the flexibility offered for vaccine storage and transport will help with vaccine logistics and application planning.
class = “cf”>
The BioNTech-Pfizer vaccine was approved by the EU in December 2020 and use of the vaccine began earlier this year.
Also in February, the United States approved the storage and transport of Pfizer vaccine between minus 15 and minus 25 degrees Celsius, instead of being stored at minus 80 degrees Celsius.
In early May, Canada cleared the Pfizer vaccine for use in children 12 to 15 years old, making it the first country to do so for this age group.
However, the storage conditions have been shown to be the biggest handicap of the BioNTech-Pfizer vaccine.
The EU has 2.4 billion doses of vaccine purchase contracts with BioNTech-Pfizer, including options.